Overview
Jack Hong is a Hematologist Oncology specialist and a Radiation Oncologist in Baltimore, Maryland. Dr. Hong is rated as an Experienced provider by MediFind in the treatment of Vulvar Cancer. His top areas of expertise are Laryngeal Cancer, Breast Cancer, Pleuropulmonary Blastoma, and Paget Disease of the Breast.
His clinical research consists of participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
22 S Green St, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
16 Clinical Trials
Sidney Kimmel Comprehensive Cancer Center
Akila Viswanathan, M.D., M.P.H., is the director for the Department of Radiation Oncology and Molecular Radiation Sciences, and a professor of radiation oncology, gynecology/obstetrics and oncology for Johns Hopkins University School of Medicine. Dr. Viswanathan leads the department emphasizing excellence in clinical care, research and education. She has expertise with gynecologic cancers and their treatment, including cervical and uterine cancers and image-guided brachytherapy. She has developed numerous clinical innovations and initiated several system-wide integration efforts at all sites, including Green Spring Station, Bayview, Johns Hopkins Hospital, Suburban's Rockledge site, and Sibley Memorial Hospital for the Johns Hopkins Department of Radiation Oncology. Dr. Viswanathan earned her undergraduate degree at Harvard University, her medical degree at the University of Pittsburgh School of Medicine, followed by her Masters in Public Health and Masters in Epidemiology at the Harvard School of Public Health. She completed a residency in radiation oncology at the Joint Center for Radiation Therapy at Harvard Medical School, where she served as chief resident. She has had research grant funding through the National Cancer Institute K07, R21 and R01 programs to support efforts in gynecologic cancers, specifically looking at the identification of gynecologic tumors at the time of brachytherapy under magnetic resonance imaging. The research team has developed several novel clinical innovations. Dr. Viswanathan has been named one of America's Top Doctors by Newsweek, Who’s who in America, and a Super Doctor by the Washington Post magazine. Dr. Viswanathan served as President and Chair of the Board of the American Brachytherapy Society; Chair of Education Committee for American Society for Radiation Oncology; and, on the Gynecologic Cancer Steering Committee and the uterine cancer task force for the National Cancer Institute. Dr. Akila Viswanathan has published more than 200 articles and chapters, and lectures nationally and internationally. She is the Editor-in-Chief for Seminars in Radiation Oncology. She is on the editorial board of Gynecologic Oncology and Brachytherapy, and is an editor of several textbooks including Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management, Radiation Therapy Techniques for Gynecologic Cancers, and Gunderson and Tepper's Clinical Radiation Oncology. Make A Gift. Dr. Viswanathan is rated as a Distinguished provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Vaginal Cancer, Cervical Cancer, Vulvar Cancer, Vulvectomy, and Cordotomy.
Cardella Coleman is a Radiation Oncologist in Baltimore, Maryland. Dr. Coleman is rated as an Advanced provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Vulvar Cancer, and Familial Prostate Cancer.
Radiation Oncologists, P.A.
Lana Lawrence is a Radiation Oncologist in Newark, Delaware. Dr. Lawrence is rated as a Distinguished provider by MediFind in the treatment of Vulvar Cancer. Her top areas of expertise are Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Endometrial Cancer, and Posterior Fossa Tumor.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Hong isDistinguished. Learn about Breast Cancer.
- Familial Prostate CancerDr. Hong isDistinguished. Learn about Familial Prostate Cancer.
- Laryngeal CancerDr. Hong isDistinguished. Learn about Laryngeal Cancer.
- Paget Disease of the BreastDr. Hong isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Hong isDistinguished. Learn about Pleuropulmonary Blastoma.
- Prostate CancerDr. Hong isDistinguished. Learn about Prostate Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Hong isAdvanced. Learn about Anal Cancer.
- Lung AdenocarcinomaDr. Hong isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Hong isAdvanced. Learn about Lung Cancer.
- Squamous Cell Lung CarcinomaDr. Hong isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Throat CancerDr. Hong isAdvanced. Learn about Throat Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Hong isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Hong isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AngiosarcomaDr. Hong isExperienced. Learn about Angiosarcoma.
- Bladder CancerDr. Hong isExperienced. Learn about Bladder Cancer.
- Bone TumorDr. Hong isExperienced. Learn about Bone Tumor.
- Breast Cancer in MenDr. Hong isExperienced. Learn about Breast Cancer in Men.

